KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 80 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Follow-Up Questions
KRMD 주식의 가격 성능은 어떻습니까?
KRMD의 현재 가격은 $3.85이며, 전 거래일에 decreased 0.12% 하였습니다.
KORU Medical Systems Inc의 주요 사업 주제나 업종은 무엇입니까?
KORU Medical Systems Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
KORU Medical Systems Inc의 시가총액은 얼마입니까?
KORU Medical Systems Inc의 현재 시가총액은 $178.2M입니다
KORU Medical Systems Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 7명의 분석가가 KORU Medical Systems Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 7명의 매수, 2명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
